KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

STIFEL FINANCIAL CORP's Holding History (CIK: 0000720672)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 29,002 Value ($000) $98 Avg Close — Range —
Q2 2018
Shares 29,520 Value ($000) $110 Avg Close — Range —
Q1 2018
Shares 32,831 Value ($000) $134 Avg Close — Range —
Q4 2017
Shares 32,531 Value ($000) $151 Avg Close — Range —
Q3 2017
Shares 30,747 Value ($000) $218 Avg Close — Range —
Q2 2017
Shares 36,447 Value ($000) $263 Avg Close — Range —
Q1 2017
Shares 33,736 Value ($000) $207 Avg Close — Range —
Q4 2016
Shares 30,258 Value ($000) $178 Avg Close — Range —
Q2 2016
Shares 25,501 Value ($000) $170 Avg Close — Range —
Q4 2015
Shares 10,114 Value ($000) $51 Avg Close — Range —
Q3 2015
Shares 20,865 Value ($000) $74 Avg Close — Range —
Q2 2015
Shares 50,027 Value ($000) $499 Avg Close — Range —
Q1 2015
Shares 34,704 Value ($000) $443 Avg Close — Range —
Q4 2014
Shares 30,747 Value ($000) $435 Avg Close — Range —
Q3 2014
Shares 19,346 Value ($000) $266 Avg Close — Range —
Q2 2014
Shares 791,982 Value ($000) $12,181 Avg Close — Range —
Q1 2014
Shares 955,107 Value ($000) $16,275 Avg Close — Range —